NAVIDEA BIOPHARMACEUTICALS, INC. 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Jan 31, 2014
Insider Transaction Report
Form 4
LARSON BRENT L
VP Finance and CFO
Transactions
- Award
Stock Option (Right to Buy)
2014-01-28+124,000→ 124,000 totalExercise: $1.77Exp: 2024-01-28→ Common Stock (124,000 underlying)
Footnotes (1)
- [F1]Option vests 25% per year beginning on the first anniversary of the date of grant.